RISS STAGE II PLASMA CELL MYELOMA

Clinical trials for RISS STAGE II PLASMA CELL MYELOMA explained in plain language.

Never miss a new study

Get alerted when new RISS STAGE II PLASMA CELL MYELOMA trials appear

Sign up with your email to follow new studies for RISS STAGE II PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for myeloma: 4-Drug cocktail tested in major trial

Disease control Recruiting now

This study tests whether adding a fourth drug (bortezomib) to a standard three-drug regimen (daratumumab, lenalidomide, dexamethasone) helps people with newly diagnosed multiple myeloma live longer or keep cancer from coming back. About 1,450 adults who are not eligible for early…

Matched conditions: RISS STAGE II PLASMA CELL MYELOMA

Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Apr 29, 2026 06:25 UTC

RISS STAGE II PLASMA CELL MYELOMA

Get alerted when new RISS STAGE II PLASMA CELL MYELOMA trials appear

New hope for myeloma: 4-Drug cocktail tested in major trial